D
BeOne Medicines Ltd. BEIGF
$22.51 $6.5641.13% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Revenue 17.72% -6.00%
Total Other Revenue -- --
Total Revenue 17.72% -6.00%
Cost of Revenue 317.87% -4.63%
Gross Profit -34.28% -6.23%
SG&A Expenses 17.12% -13.55%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 10.96% -12.46%
Operating Income 691.61% 114.80%
Income Before Tax 376.31% 131.84%
Income Tax Expenses -73.36% -73.50%
Earnings from Continuing Operations 7,326.77% 100.91%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 7,326.77% 100.91%
EBIT 691.61% 114.80%
EBITDA 175.55% 228.51%
EPS Basic 7,216.81% 100.91%
Normalized Basic EPS 341.43% 135.53%
EPS Diluted 6,742.11% 100.87%
Normalized Diluted EPS 341.60% 134.18%
Average Basic Shares Outstanding 1.30% 0.63%
Average Diluted Shares Outstanding 1.25% 4.62%
Dividend Per Share -- --
Payout Ratio -- --